5Griffin MR. Epidemiology of nonsteroidal anti-inflammatory drug-associated gastrointestinal injury [ J]. Am J Med, 1998, 104 (3A) : 23S-29S.
6Meyer JM, Silliman NP, Wang W, et al. Risk factors for Helicobacter pylori resistance in the United States : the surveillance of H. pylori antimicrobial resistance partnership (SHARP) study, 1993-1999 [ J ]. Ann Intern Med, 2002, 136(1): 13-24.
7Van Zanten SJ, Kolesnikow T, Leung V, et al. Gastric transitional zones, areas where Helicobacter treatment fails: results of a treatment trial using the Sydney strain mouse model [ J ]. Antimicrob Agents Chemother, 2003, 47 (7) : 2249-2255.
